Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LT-002-158 in Moderate-to-Severe Atopic Dermatitis
NCT07895615Phase 2Recruiting
- Sponsor
- Leadingtac
- Start
- Oct 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 2 trial of LT-002 in atopic dermatitis (AD), sponsored by Leadingtac. Started Oct 2026; status: recruiting.
02
Drugs
LT-002
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07895615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07895615.